Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Shares Outstanding (Weighted Average) (2016 - 2019)

Historic Shares Outstanding (Weighted Average) for Soleno Therapeutics (SLNO) over the last 7 years, with Q2 2019 value amounting to $31.8 million.

  • Soleno Therapeutics' Shares Outstanding (Weighted Average) rose 5618.71% to $31.8 million in Q2 2019 from the same period last year, while for Jun 2019 it was $31.8 million, marking a year-over-year increase of 5618.71%. This contributed to the annual value of $21.0 million for FY2018, which is 13363.73% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Shares Outstanding (Weighted Average) of $31.8 million as of Q2 2019, which was up 5618.71% from $31.8 million recorded in Q1 2019.
  • Soleno Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $14.8 billion for Q1 2016, and its period low was $3.1 million during Q4 2016.
  • Over the past 5 years, Soleno Therapeutics' median Shares Outstanding (Weighted Average) value was $9.9 million (recorded in 2015), while the average stood at $835.1 million.
  • In the last 5 years, Soleno Therapeutics' Shares Outstanding (Weighted Average) skyrocketed by 21232057.44% in 2016 and then tumbled by 9996.56% in 2017.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Shares Outstanding (Weighted Average) stood at $9.4 million in 2015, then crashed by 67.1% to $3.1 million in 2016, then soared by 189.47% to $9.0 million in 2017, then skyrocketed by 133.64% to $21.0 million in 2018, then surged by 51.5% to $31.8 million in 2019.
  • Its Shares Outstanding (Weighted Average) stands at $31.8 million for Q2 2019, versus $31.8 million for Q1 2019 and $21.0 million for Q4 2018.